To celebrate the return of Hemospray, here is a summary of 3 recent Hemospray papers from the same group.
Hemospray for bleeding peptic ulcer disease (PUD) in @endoscopyjrnl
📅 Jan 16-March 19
🏥 14
🤕 202
✅ Immediate haemostasis: 88%
🩸 30d Rebleeding: 17%
⚰️ 30d Mortality: 22% (32% if monotherapy)
💡 "High immediate haemostasis rates for bleeding PUD"
thieme-connect.de/products/ejour…
Hemospray for bleeding post UGI therapy @UEGJournal
📅 Jan 16-Nov 19
🏥 16
🤕 73
✅ Immediate haemostasis: 100%
🩸 30d Rebleeding: 4%
⚰️ 30d Mortality: 2% (5% if monotherapy)
💡 "Safe and effective... with low re-bleed rate"
journals.sagepub.com/doi/full/10.11…
Hemospray for UGIB #DEN
📅 Jan 16-May 18
🏥 12
🤕 314
✅ Immediate haemostasis: 100%
🩸 30d Rebleeding: 10%
⚰️ 30d Mortality: 20% (25% if monotherapy)
💡 "Rebleeding and mortality rates were in keeping/lower than predicted rates."
onlinelibrary.wiley.com/doi/full/10.11…
My take:
🔸Avoid using Hemospray as monotherapy, esp for PUD
🔸Good for immediate haemostasis, but can cause problems for colleagues later
🔸High rebleed/mortality rates, esp if monotherapy
🔸A salami approach can cause issues with meta-analyses, esp if outcomes are repeated
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.